Items where authors include "Silva, S."
Article
Schumacher, A.E., Kyu, H.H., Aali, A. et al. (1833 more authors) (2024) Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. The Lancet, 403 (10440). pp. 1989-2056. ISSN 0140-6736
Bhattacharjee, N.V., Schumacher, A.E., Aali, A. et al. (1403 more authors) (2024) Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. The Lancet, 403 (10440). pp. 2057-2099. ISSN 0140-6736
Ferrari, A.J., Santomauro, D.F., Aali, A. et al. (1325 more authors) (2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403 (10440). pp. 2133-2161. ISSN 0140-6736
Vollset, S.E., Ababneh, H.S., Abate, Y.H. et al. (1417 more authors) (2024) Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet, 403 (10440). pp. 2204-2256. ISSN 0140-6736
Brauer, M., Roth, G.A., Aravkin, A.Y. et al. (1792 more authors) (2024) Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403 (10440). pp. 2162-2203. ISSN 0140-6736
Naghavi, M., Ong, K.L., Aali, A. et al. (1997 more authors) (2024) Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403 (10440). pp. 2100-2132. ISSN 0140-6736
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Terrado, M., Marcos, R., González-Reviriego, N. et al. (12 more authors) (2023) Co-production pathway of an end-to-end climate service for improved decision-making in the wine sector. Climate Services, 30. 100347. ISSN 2405-8807
Coombes, R.C., Tovey, H., Kilburn, L. et al. (230 more authors) (2021) Effect of celecoxib vs placebo as adjuvant therapy on disease-free survival among patients with breast cancer. JAMA Oncology, 7 (9). p. 1291. ISSN 2374-2437
Coen, O., Corrie, P., Marshall, H. et al. (17 more authors) (2021) The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma. BMC Cancer, 21 (1). 761. ISSN 1471-2407
Silva, S., Danson, S., Teare, M.D. et al. (12 more authors) (2018) Genome-wide analysis of circulating cell-free DNA copy number detects active melanoma and predicts survival. Clinical Chemistry, 64 (9). pp. 1338-1346. ISSN 0009-9147